Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess insulin action on peripheral glucose utilization and nonesterified fatty acid (NEFA) suppression as a predictor of coronary artery calcification (CAC) in patients with type 1 diabetes and nondiabetic controls. RESEARCH DESIGN AND METHODS: Insulin action was measured by a three-stage hyperinsulinemic-euglycemic clamp (4, 8, and 40 mU/m2/min) in 87 subjects from the Coronary Artery Calcification in Type 1 Diabetes cohort (40 diabetic, 47 nondiabetic; mean age 45 ± 8 years; 55% female). RESULTS: Peripheral glucose utilization was lower in subjects with type 1 diabetes compared with nondiabetic controls: glucose infusion rate (mg/kg FFM/min) = 6.19 ± 0.72 vs. 12.71 ± 0.66, mean ± SE, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and final clamp glucose and insulin. Insulin-induced NEFA suppression was also lower in type 1 diabetic compared with nondiabetic subjects: NEFA levels (μM) during 8 mU/m2/min insulin infusion = 370 ± 27 vs. 185 ± 25, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and time point insulin. Lower glucose utilization and higher NEFA levels, correlated with CAC volume (r = −0.42, P < 0.0001 and r = 0.41, P < 0.0001, respectively) and predicted the presence of CAC (odds ratio [OR] = 0.45, 95% CI = 0.22–0.93, P = 0.03; OR = 2.4, 95% CI = 1.08–5.32, P = 0.032, respectively). Insulin resistance did not correlate with GHb or continuous glucose monitoring parameters. CONCLUSIONS: Type 1 diabetic patients are insulin resistant compared with nondiabetic subjects, and the degree of resistance is not related to current glycemic control. Insulin resistance predicts the extent of coronary artery calcification and may contribute to the increased risk of cardiovascular disease in patients with type 1 diabetes as well as subjects without diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Excess adiposity was associated with inadequate glycemic control in patients with T1D in the T1D Exchange study cohort.34”
From Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes (2025) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786 · cited 1×
“Calcium volume scores (CVS) were calculated using the volumetric method, which is based on isotropic interpolation, as previously described (40,41).”
MethodGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“5 hours using the method of DeFronzo et al (39).”
MethodInfluentialIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760 · cited 1×
“Insulin resistance has been strongly implicated as a cardiovascular risk factor in the general population(17-25).”
Background(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Self-citationKrolewski, A. S., Kosinski, E. J., Warram, J. H., Stevens Leland, O., Busick, E. J., Cader Asmal, A., Rand, L. I., Christlieb, A. R., Bradley, R. F., & Kahn, C. R. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91086-1 · Cited by 654 · cited 2×
“9mmol/L), (3) Hyperglycemia, percentage of glucose values >180mg/dl (10mmol/L), and (4)Glycemic variability within days, overall standard deviation (SDT), the standard deviation of all glucose values.”
Background(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Can clinical factors estimate insulin resistance in type 1 diabetes?
Williams, K. V., Erbey, J. R., Becker, D., Arslanian, S., & Orchard, T. J. (2000) · Diabetes · doi:10.2337/diabetes.49.4.626 · Cited by 640 · cited 1×
“5-10 defined the low risk group, and a GHb difference representing the full range of our diabetic subjects would result in only a 1 mg/kg/min change in GIR(27).”
BackgroundHanley, A. J. G., Williams, K., Stern, M. P., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1177 · Cited by 637 · cited 1×
“Insulin resistance has been strongly implicated as a cardiovascular risk factor in the general population(17-25).”
BackgroundBonora, E., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1135 · Cited by 604 · cited 1×
“Insulin resistance has been strongly implicated as a cardiovascular risk factor in the general population(17-25).”
BackgroundDiabetes Control and Complications Trial
Yue, D., Colagiuri, S., McElduff, A., & Silink, M. (1993) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb141357.x · Cited by 575
Orchard, T. J., Olson, J. C., Erbey, J. R., Williams, K., Forrest, K. Y.-Z., Smithline Kinder, L., Ellis, D., & Becker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1374 · Cited by 492 · cited 2×
“The Pittsburgh Epidemiology of Diabetes Study demonstrated a correlation between estimated insulin resistance and coronary artery disease (10).”
BackgroundInsulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2007) · Diabetes Care · doi:10.2337/dc06-1982 · Cited by 439
Insulin Resistance is a Prominent Feature of Insulin-dependent Diabetes
DeFronzo, R. A., Hendler, R., & Simonson, D. (1982) · Diabetes · doi:10.2337/diab.31.9.795 · Cited by 365 · cited 1×
“These findings, consistent with previous smaller studies(29; 31)(28), suggest a novel component in the”
ResultVascular function, insulin resistance and fatty acids
Steinberg, H., & Baron, A. (2002) · Diabetologia · doi:10.1007/s00125-002-0800-2 · Cited by 341
Nadeau, K. J., Regensteiner, J. G., Bauer, T. A., Brown, M. S., Dorosz, J. L., Hull, A., Zeitler, P., Draznin, B., & Reusch, J. E. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1756 · Cited by 309 · cited 1×
“These findings, consistent with previous smaller studies (28,29,31), suggest a novel component in the etiology of insulin resistance in type 1 diabetes.”
ResultType 1 diabetes and coronary artery disease
Orchard, T. J., Costacou, T., Kretowski, A., & Nesto, R. W. (2006) · Diabetes Care · doi:10.2337/dc06-1161 · Cited by 305
Self-citationNatural Course of Insulin Resistance in Type I Diabetes
Yki-Järvinen, H., & Koivisto, V. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150404 · Cited by 304
Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease
Jeppesen, J., Hansen, T. W., Rasmussen, S., Ibsen, H., Torp-Pedersen, C., & Madsbad, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.088 · Cited by 286 · cited 1×
“Insulin resistance has been strongly implicated as a cardiovascular risk factor in the general population(17-25).”
BackgroundJouven, X., Charles, M.-A., Desnos, M., & Ducimetière, P. (2001) · Circulation · doi:10.1161/hc3201.094151 · Cited by 256
Dabelea, D., Kinney, G., Snell-Bergeon, J. K., Hokanson, J. E., Eckel, R. H., Ehrlich, J., Garg, S., Hamman, R. F., & Rewers, M. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2833 · Cited by 250 · cited 2×
“The Coronary Artery Calcification in Type 1 Diabetes (CACTI) study has followed a cohort of type 1 diabetic subjects and similar nondiabetic controls with electron beam computed tomography for measurement of coronary artery calcification (CAC) and CVD outcomes for 6 years (15,38).”
BackgroundMethodSelf-citationIncreased serum adiponectin levels in type 1 diabetic patients with microvascular complications
Frystyk, J., Tarnow, L., Krarup Hansen, T., Parving, H.-H., & Flyvbjerg, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1850-z · Cited by 223 · cited 1×
“Adiponectin was significantly higher in type 1 diabetic than non-diabetic subjects as has been reported previously (42-45).”
ResultHyperglycemia Decreases Glucose Uptake in Type I Diabetes
Yki-Järvinen, H., Helve, E., & Koivisto, V. A. (1987) · Diabetes · doi:10.2337/diab.36.8.892 · Cited by 205 · cited 1×
“Finally, in the important 1986 study of Yki-Jarvinen, (46,47) the authors found improved insulin sensitivity with initiation of treatment and improved glycemic control in newly diagnosed type 1 diabetes.”
BackgroundPilz, S., Scharnagl, H., Tiran, B., Seelhorst, U., Wellnitz, B., Boehm, B. O., Schaefer, J. R., & März, W. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0195 · Cited by 200
Cardiovascular Disease and Its Risk Factors in IDDM in Europe
Koivisto, V. A., Stevens, I. K., Mattock, M., Ebeling, P., Muggeo, M., Stephenson, J., Idzior-Walus, B., & The EURODIAB IDDM Complications Study Group (1996) · Diabetes Care · doi:10.2337/diacare.19.7.689 · Cited by 198
Saely, C. H., Aczel, S., Marte, T., Langer, P., Hoefle, G., & Drexel, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0799 · Cited by 191 · cited 1×
“Insulin resistance has been strongly implicated as a cardiovascular risk factor in the general population(17-25).”
BackgroundEpidemiology of insulin resistance and its relation to coronary artery disease
Haffner, S. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00351-3 · Cited by 173 · cited 1×
“Insulin resistance has been strongly implicated as a cardiovascular risk factor in the general population(17-25).”
BackgroundForrest, K. Y. Z., BECKER, D. J., Kuller, L. H., Wolfson, S. K., & Orchard, T. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00217-8 · Cited by 159
Imagawa, A., Funahashi, T., Nakamura, T., Moriwaki, M., Tanaka, S., Nishizawa, H., Sayama, K., Uno, S., Iwahashi, H., Yamagata, K., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1665 · Cited by 156 · cited 1×
“Adiponectin was significantly higher in type 1 diabetic than non-diabetic subjects as has been reported previously (42-45).”
ResultClassical risk factors and emerging elements in the risk profile for coronary artery disease.
Gensini, G., Comeglio, M., & Colella, A. (1998) · PubMed · Cited by 147
Progression of Coronary Artery Calcification in Type 1 Diabetes
Snell-Bergeon, J. K., Hokanson, J. E., Jensen, L., MacKenzie, T., Kinney, G., Dabelea, D., Eckel, R. H., Ehrlich, J., Garg, S., & Rewers, M. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2923 · Cited by 139 · cited 1×
“The Coronary Artery Calcification in Type 1 Diabetes (CACTI) study has followed a cohort of type 1 diabetic subjects and similar nondiabetic controls with electron beam computed tomography for measurement of coronary artery calcification (CAC) and CVD outcomes for 6 years (15,38).”
BackgroundSelf-citationSerum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy
Saraheimo, M., Forsblom, C., Fagerudd, J., Teppo, A.-M., Pettersson-Fernholm, K., Frystyk, J., Flyvbjerg, A., Groop, P.-H., & on behalf of the FinnDiane Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1410 · Cited by 131 · cited 1×
“Adiponectin was significantly higher in type 1 diabetic than non-diabetic subjects as has been reported previously (42-45).”
ResultDiabetes and coronary artery disease
Arvind, K., Pradeepa, R., Deepa, R., & Mohan (2002) · Cited by 105
Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.1014 · Cited by 105
Carlsson, M., Wessman, Y., Almgren, P., & Groop, L. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1588 · Cited by 95
Deficiencies of Cardiovascular Risk Prediction Models for Type 1 Diabetes
Zgibor, J. C., Piatt, G. A., Ruppert, K., Orchard, T. J., & Roberts, M. S. (2006) · Diabetes Care · doi:10.2337/dc06-0290 · Cited by 93 · cited 2×
“This is consistent with a previous report that standard prediction models of CVD risk (highly dependent on hypertension and lipids) do not accurately predict CVD risk in the type 1 diabetic population (16).”
BackgroundResultAddressing insulin resistance in Type 1 diabetes
Pang, T. T. L., & Narendran, P. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02493.x · Cited by 78 · cited 1×
“Similar correlations of estimated insulin resistance or a surrogate of insulin resistance (waist-to-hip ratio) to coronary artery disease were also found in the Diabetes Control and Complications Trial (DCCT) and the EURODIAB study (33).”
ResultProgression of coronary artery calcification in diabetics with and without chronic kidney disease
Mehrotra, R., Budoff, M. J., Hokanson, J. E., Ipp, E., Takasu, J., & Adler, S. G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00522.x · Cited by 73 · cited 1×
“Calcium volume scores (CVS) were calculated using the volumetric method, which is based on isotropic interpolation, as previously described (40,41).”
MethodLong-term predictors of coronary artery disease and mortality in type 1 diabetes
Weis, U. (2001) · QJM · doi:10.1093/qjmed/94.11.623 · Cited by 66
Maahs, D. M., Hokanson, J. E., Wang, H., Kinney, G. L., Snell-Bergeon, J. K., East, A., Bergman, B. C., Schauer, I. E., Rewers, M., & Eckel, R. H. (2010) · Diabetes · doi:10.2337/db09-1626 · Cited by 61
Self-citationInsulin resistance is a prominent feature of patients with pancreatogenic diabetes
Yki‐Järvinen, H., Kiviluoto, T. A., & Taskinen, M. (1986) · Metabolism · doi:10.1016/0026-0495(86)90239-8 · Cited by 49 · cited 1×
“These findings, consistent with previous smaller studies (28,29,31), suggest a novel component in the etiology of insulin resistance in type 1 diabetes.”
ResultDorman, J. S., Tajima, N., LaPorte, R. E., Becker, D. J., Cruickshanks, K. J., Wagener, D. K., Orchard, T. J., & DRASH, A. L. (1985) · Diabetes Care · doi:10.2337/diacare.8.1.s54 · Cited by 48
Insulin sensitivity and vascular disease in insulin-dependent diabetics.
Martin, F. I. R., & Stocks, A. E. (1968) · BMJ · doi:10.1136/bmj.2.5597.81 · Cited by 46 · cited 1×
“between this index and prevalent macrovascular disease in type 1 diabetic subjects (30).”
BackgroundDeterminants of Serum Adiponectin in Persons with and without Type 1 Diabetes
Maahs, D. M., Ogden, L. G., Snell-Bergeon, J. K., Kinney, G. L., Wadwa, R. P., Hokanson, J. E., Dabelea, D., Kretowski, A., Eckel, R. H., & Rewers, M. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm125 · Cited by 46 · cited 1×
“Adiponectin was significantly higher in type 1 diabetic than non-diabetic subjects as has been reported previously (42-45).”
ResultSelf-citationInsulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues
Yki‐Järvinen, H., & Mäkimattila, S. (1997) · Diabetologia · doi:10.1007/s001250051431 · Cited by 18 · cited 1×
“Finally, in the important 1986 study of Yki-Jarvinen, (46,47) the authors found improved insulin sensitivity with initiation of treatment and improved glycemic control in newly diagnosed type 1 diabetes.”
BackgroundInsulin-resistance, hypertriglyceridaemia and cardiovascular risk: the Paris Prospective Study.
Fontbonne, A., & Eschwège, É. (1991) · PubMed · Cited by 18
Cited by
Insulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 858
The crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 557
de Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 503
“More recently, a subgroup of the CACTI study underwent euglycemic clamps, and results showed that insulin resistance in T1DM patients compared with nondiabetic subjects was not related to their current level of glycemic control and yet predicted the extent of CAC.(157) by gest on O cber 4, 2017 http://ciajournals.”
ResultSelf-citationde Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 433
Self-citationInsulin resistance is a cardiovascular risk factor in humans
Adeva-Andany, M. M., Martínez-Rodríguez, J., González-Lucán, M., Fernández-Fernández, C., & Castro-Quintela, E. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.02.023 · Cited by 313
Metadata
- Authors
- Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M.
- Affiliations
- University of Colorado Anschutz (US)
- Barbara Davis Center for Childhood Diabetes, School of Medicine, University of Colorado Denver, Aurora, Colorado.
- Corresponding author
- Schauer, Irene E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-10-26
- Volume
- 60
- Issue
- 1
- Pages
- 306-314
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3012187
- OpenAlex
- W2140420590
- Cited by
- 230
- References
- 50
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 13 · 2023: 13 · 2022: 11 · 2021: 23 · 2020: 13 · 2019: 15 · 2018: 11 · 2017: 19 · 2016: 9 · 2015: 24 · 2014: 17 · 2013: 13 · 2012: 17
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (BIRCWH K12 Program, P30 DK)
- National Heart, Lung, and Blood Institute (R01HL113029, HL61753, R01HL61753, R01HL061753, R01HL079611)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, P30 DK 57516)
- National Center for Research Resources (M01RR000051)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin resistance, type 1 diabetes, coronary artery calcification, free fatty acids, peripheral glucose utilization, hyperinsulinemic-euglycemic clamp, cardiovascular risk, glycemic control, HbA1c, continuous glucose monitoring, atherosclerosis, diabetic cardiomyopathy, dyslipidemia, dyslipoproteinemia
- MeSH terms
- Abdomen, Adipose Tissue, Adult, Blood Glucose, Body Composition, Calcium, Coronary Vessels, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Environmental Monitoring, Fatty Acids, Fatty Acids, Nonesterified, Female, Glycerol, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Reference Values, Spleen, Tomography, X-Ray Computed, Glucose Clamp Technique, Cohort Studies, Absorptiometry, Photon, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.